Skip to main
ZYXI
ZYXI logo

Zynex Inc (ZYXI) Stock Forecast & Price Target

Zynex Inc (ZYXI) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 33%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Zynex Inc. demonstrated a promising growth trajectory, with orders increasing by 16% year-over-year in FY2024, suggesting strong market demand for its electrotherapy and pain management products. The company's commitment to innovative technology was underscored by positive results from the NiCo verification clinical study, which highlighted Zynex's laser-based system as superior to traditional pulse oximeters, potentially enhancing its market competitiveness. Furthermore, cost reduction initiatives projected to yield approximately $35 million in annual savings, combined with strategic goals to improve sales rep productivity and product penetration, indicate a robust operational outlook that could drive future revenue growth.

Bears say

Zynex Inc. has indicated a challenging financial outlook, with projected Q1 2025 sales of “at least $30 million,” representing a significant decrease of 37% year-over-year and 35% sequentially, alongside an anticipated EPS loss of $0.30. The company reported Q4 2024 total revenue of $46 million, reflecting a 3% year-over-year decline and falling short of projections, driven by a notable 9% decrease in Device sales. Additionally, the overall business environment is characterized by high competition in the pain management sector and uncertainties regarding regulatory approvals for new products, leading to a revised sales forecast for 2025 of $140 million, a 28% reduction from prior estimates.

Zynex Inc (ZYXI) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 33% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Zynex Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Zynex Inc (ZYXI) Forecast

Analysts have given Zynex Inc (ZYXI) a Buy based on their latest research and market trends.

According to 6 analysts, Zynex Inc (ZYXI) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Zynex Inc (ZYXI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.